Drugmakers Are Abandoning Cheap Generics, and Now US Cancer Patients Can’t Get Meds
The US is is abandoning treatable patients, first by not providing reasonably priced insulin, now by ignoring cancer drug shortages.
Read more...The US is is abandoning treatable patients, first by not providing reasonably priced insulin, now by ignoring cancer drug shortages.
Read more...When you thought the US might finally have hit bottom on the China front, we show we can reach new lows.
Read more...An argument that spending on Ukraine is not quite as unproductive as it seems.
Read more...The bloody war in Ukraine has reached the carnage phase, as least for Urkaine’s men and their backers.
Read more...Readouts from a meeting between Anthony Blinken and his counterpart Qin Gang indicate the US and China are barely communicating.
Read more...Paul Jay on Ellsberg: “Dan fearlessly risked everything in his unwavering quest for social justice and opposition to war. “
Read more...America continues to be exceptional, here in our level of excess deaths.
Read more...Satyajit Das provides a series on the energy transition, starting with the historical role of energy and supply and demand patterns.
Read more...As bad air becomes a new normal, advanced economies grapple with impact of sooty wildfire smoke on top of existing pollutants.
Read more...Michael Hudson gives a globe-spanning look at recent economic and geopolitical events.
Read more...Every bank crisis has its own overarching narrative and streams of sub-narratives that course through the marketplace day to day.
Read more...The war on terror’s high costs are buried in the US.
Read more...Is Russia moving towards the perceived necessity of subduing western Ukraine? And how might that work?
Read more...Solar panels have a roughly 15 year life. Where do they go to die? The answers now are not very good.
Read more...The West is trying to use the Ukraine grain deal to stymie Russia…..with ample support from the UN’s Guterres.
Read more...